5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 374.61▼ | 375.88▼ |
MA10 | N/A | N/A | N/A | 373.99▼ | 385.35▼ |
MA20 | N/A | N/A | N/A | 378.67▼ | 402.05▼ |
MA50 | N/A | N/A | N/A | 392.11▼ | 431.43▼ |
MA100 | N/A | N/A | N/A | 402.99▼ | 461.24▼ |
MA200 | N/A | N/A | N/A | 416.45▼ | 464.23▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | -0.781▼ | -3.268▼ |
RSI | N/A | N/A | N/A | 36.413▼ | 31.187▼ |
STOCH | N/A | N/A | N/A | 45.956 | 26.301 |
WILL %R | N/A | N/A | N/A | -91.821▼ | -96.135▼ |
CCI | N/A | N/A | N/A | -278.224▼ | -105.189▼ |
Wednesday, April 30, 2025 06:36 AM
GSK (LSE:GSK) reported a significant improvement in its first-quarter earnings, with sales, net income, and earnings per share all showing promising growth. This announcement coincided with a 5.14 ...
|
Wednesday, April 09, 2025 07:48 AM
AstraZeneca (LSE:AZN) saw its share price decline by 3.5% in the last quarter, a period marked by several key developments, including the European approval of DATROWAY for breast cancer treatment ...
|
Tuesday, April 01, 2025 05:00 PM
Fintel reports that on April 9, 2025, Guggenheim initiated coverage of Elevance Health (LSE:0HG8) with a Buy recommendation.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 356.00 | 357.21 | 348.00 | 352.28 | 729 |
02/07/25 | 380.00 | 395.76 | 356.9152 | 357.6571 | 10,551 |
01/07/25 | 390.02 | 400.33 | 388.1864 | 400.33 | 423 |
30/06/25 | 381.00 | 388.99 | 378.77 | 384.14 | 108 |
27/06/25 | 373.00 | 380.00 | 373.00 | 378.62 | 440 |
26/06/25 | 373.50 | 378.72 | 373.50 | 373.69 | 118 |
25/06/25 | 378.00 | 378.00 | 371.50 | 373.59 | 523 |
24/06/25 | 373.90 | 374.90 | 369.00 | 373.98 | 129 |
23/06/25 | 376.26 | 376.26 | 370.86 | 371.72 | 45 |
20/06/25 | 377.075 | 378.785 | 371.975 | 373.89 | 380 |
|
|
||||
|
|
||||
|
|